Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.
Affiliation
Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa.Issue Date
2004-04-09
Metadata
Show full item recordJournal
AIDS (London, England)Abstract
BACKGROUND: A community-based antiretroviral therapy (ART) programme was established in 2001 in a South African township to explore the operational issues involved in providing ART in the public sector in resource-limited settings and demonstrate the feasibility of such a service. METHODS: Data was analysed on a cohort of patients with symptomatic HIV disease and a CD4 lymphocyte count < 200 x 10 cells/l. The programme used standardized protocols (using generic medicines whenever possible), a team-approach to clinical care and a patient-centred approach to promote adherence. RESULTS: Two-hundred and eighty-seven adults naive to prior ART were followed for a median duration of 13.9 months. The median CD4 lymphocyte count was 43 x 10 cells/l at initiation of treatment, and the mean log10 HIV RNA was 5.18 copies/ml. The HIV RNA level was undetectable (< 400 copies/ml) in 88.1, 89.2, 84.2, 75.0 and 69.7% of patients at 3, 6, 12, 18 and 24 months respectively. The cumulative probability of remaining alive was 86.3% at 24 months on treatment for all patients, 91.4% for those with a baseline CD4 lymphocyte count > or =50 x 10 cells/l, and 81.8% for those with a baseline CD4 lymphocyte count < 50 x 10 cells/l. The cumulative probability of changing a single antiretroviral drug by 24 months was 15.1% due to adverse events or contraindications, and 8.4% due to adverse events alone. CONCLUSIONS: ART can be provided in resource-limited settings with good patient retention and clinical outcomes. With responsible implementation, ART is a key component of a comprehensive response to the epidemic in those communities most affected by HIV.PubMed ID
15060436Language
enISSN
0269-9370Collections
Related articles
- Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study.
- Authors: Moosa A, Gengiah TN, Lewis L, Naidoo K
- Issue date: 2019 Sep 5
- Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.
- Authors: Bekker LG, Myer L, Orrell C, Lawn S, Wood R
- Issue date: 2006 Apr
- Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
- Authors: Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, Mathee S, Ford N, Knight L, Osler M, Myers J, Goemaere E, Coetzee D, Maartens G
- Issue date: 2010 Feb 20
- Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
- Authors: Cornell M, Johnson LF, Wood R, Tanser F, Fox MP, Prozesky H, Schomaker M, Egger M, Davies MA, Boulle A, International Epidemiology Databases to Evaluate AIDS-Southern Africa collaboration.
- Issue date: 2017 Sep 25
- Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa.
- Authors: Fatti G, Mothibi E, Shaikh N, Grimwood A
- Issue date: 2016 Nov